scholarly journals Alkaline phosphatase (ALP) in liver diseases with special reference to metabolic disorder of glucose.

Kanzo ◽  
1977 ◽  
Vol 18 (5) ◽  
pp. 314-318
Author(s):  
Hideo NISHIMURA ◽  
Daizo KAN ◽  
Junsuke NAWATA ◽  
Mituru ODAWARA ◽  
Mikio HAYAKAWA ◽  
...  
Author(s):  
OSMAN Oğuz ◽  
Huriye Serin ◽  
Fatma Hocaoğlu Emre

Background: Alkaline phosphatase (ALP) enzymes are widely used as signal amplifiers in immunoenzymatic methods. Conditions that cause ALP elevations, such as bone or liver diseases can cause interference in immunoenzymatic methods. Objective: We aimed to examine ALP's effect on immunoenzymatic assay by adding isolated pure ALP to the prepared serum pool. Material and Methods: We prepared a serum pool and divided into 4 groups. By adding isolated pure ALP at different concentrations to each group, we obtained sample groups containing ALP enzyme at concentrations of 85 U/L, 340 U/L, 870 U/L and 1570 U/L. In each group, 20-repetition of βhCG, Ferritin, FT4, TSH, Troponin I and Vit B12 tests were performed. Coefficient of variation, bias, and total error were calculated. All groups were compared by using Friedman test for paired samples. Result: After ALP addition, the calculated total error values of FT4, βhCG and troponin I tests were found to be above the acceptable error limits. There were statistically significant differences in βhCG ,FT4, troponin I and Vit B12 tests when compared to the baseline ALP level (P<0,0125).Conclusion: Isolated ALP elevations can be a source of interference for immunoenzymatic methods.KeywordsAlkaline phosphatase, ALP, bias, immunoenzymatic, total error


Sign in / Sign up

Export Citation Format

Share Document